Structure-based identification of a non-covalent thioredoxin reductase inhibitor with proven ADMET suitability
{{output}}
Thioredoxin reductase 1 (TrxR1), a selenoprotein enzyme crucial for redox homeostasis in mammals, has emerged as a promising target for anticancer therapy. In this study, we present a non-covalent TrxR1 inhibitor, identified through an integrated experimental ... ...